{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T08:08:07Z","timestamp":1770710887508,"version":"3.49.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Assist Reprod Genet"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1007\/s10815-008-9249-7","type":"journal-article","created":{"date-parts":[[2008,9,18]],"date-time":"2008-09-18T12:06:51Z","timestamp":1221739611000},"page":"365-374","source":"Crossref","is-referenced-by-count":44,"title":["Comparison of embryological and clinical outcome in GnRH antagonist vs. GnRH agonist protocols for in vitro fertilization in PCOS non-obese patients. A prospective randomized study"],"prefix":"10.1007","volume":"25","author":[{"given":"Rafal","family":"Kurzawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Przemyslaw","family":"Ciepiela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"Baczkowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krzysztof","family":"Safranow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pawel","family":"Brelik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,9,19]]},"reference":[{"key":"9249_CR1","first-page":"2434","volume":"85","author":"M Asuncion","year":"2000","unstructured":"Asuncion M, Calvo RM, San Millan JL. A prospective study of the prevalence of the polycystic ovary in unselected Caucasian women from Spain. J Clin Endocrinol Metab 2000;85:2434\u20138. doi: 10.1210\/jc.85.7.2434 .","journal-title":"J Clin Endocrinol Metab"},{"key":"9249_CR2","first-page":"3078","volume":"83","author":"ES Knochenhauer","year":"1998","unstructured":"Knochenhauer ES, Key TJ, Kahsar-Miller M. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States; a prospective study. J Clin Endocrinol Metab 1998;83:3078\u201382. doi: 10.1210\/jc.83.9.3078 .","journal-title":"J Clin Endocrinol Metab"},{"key":"9249_CR3","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1093\/humrep\/dem426","volume":"23","author":"Thessaloniki ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2008","unstructured":"Thessaloniki ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Hum Reprod 2008;23:462\u201377. doi: 10.1093\/humrep\/dem426 .","journal-title":"Hum Reprod"},{"key":"9249_CR4","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.bpobgyn.2004.05.006","volume":"18","author":"R Homburg","year":"2004","unstructured":"Homburg R. Management of infertility and prevention of ovarian hyperstimulation in women with polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 2004;18:773\u201388. doi: 10.1016\/j.bpobgyn.2004.05.006 .","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"9249_CR5","first-page":"83","volume-title":"A textbook of in vitro fertilization and assisted reproduction","author":"FT Akagbosu","year":"1999","unstructured":"Akagbosu FT. The use of GnRH agonists and antagonists in infertility. In: Brinsden PR, editor. A textbook of in vitro fertilization and assisted reproduction. New York, USA: Partheon; 1999. p. 83\u20139."},{"key":"9249_CR6","first-page":"5","volume":"5","author":"KS Moghissi","year":"2000","unstructured":"Moghissi KS. A clinician\u2019s guide to use of gonadotropin-releasing hormone analogs in women. Medscape Womens Health 2000;5:5.","journal-title":"Medscape Womens Health"},{"key":"9249_CR7","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1093\/oxfordjournals.humrep.a136219","volume":"10","author":"T Reissmann","year":"1995","unstructured":"Reissmann T, Felberbaum R, Diedrich K, Engel J, Comaru-Schally AM, Schally AV. Development and applications of luteinizing hormone-releasing hormone antagonists in the treatment of infertility. Hum Reprod 1995;10:1974\u201381.","journal-title":"Hum Reprod"},{"key":"9249_CR8","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/humupd\/dml038","volume":"12","author":"EM Kolibianakis","year":"2006","unstructured":"Kolibianakis EM, Collins J, Tarlatzis BC, Devroey P, Diedrich K, Griesinger G. Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis. Hum Reprod Update 2006;12:651\u201371. doi: 10.1093\/humupd\/dml038 .","journal-title":"Hum Reprod Update"},{"key":"9249_CR9","doi-asserted-by":"crossref","unstructured":"Al-Inany HG, Abou-Setta AM, Aboulghar M. Gonadotrophin-releasing hormone antagonists for assisted conception. Cochrane Database of Systematic Reviews 2006, Issue 3. Art. No.: CD001750. doi: 10.1002\/14651858.CD001750.pub2","DOI":"10.1002\/14651858.CD001750.pub2"},{"key":"9249_CR10","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S1472-6483(10)61059-0","volume":"14","author":"HG Al-Inany","year":"2007","unstructured":"Al-Inany HG, Abou-Setta AM, Aboulghar M. Gonadotrophin-releasing hormone antagonists for assisted conception: a Cochrane Review. Reprod Biomed Online 2007;14:640\u20139.","journal-title":"Reprod Biomed Online"},{"key":"9249_CR11","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/S1472-6483(10)60652-9","volume":"13","author":"G Griesinger","year":"2006","unstructured":"Griesinger G, Diedrich K, Tarlatzis BC, Kolibianakis EM. GnRH-antagonists in ovarian stimulation for IVF in patients with poor response to gonadotrophins, polycystic ovary syndrome, and risk of ovarian hyperstimulation: a meta-analysis. Reprod Biomed Online 2006;13:628\u201338.","journal-title":"Reprod Biomed Online"},{"key":"9249_CR12","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1093\/humrep\/16.6.1086","volume":"16","author":"P Fedorcs\u00e1k","year":"2001","unstructured":"Fedorcs\u00e1k P, Dale PO, Storeng R, Tanbo T, Abyholm T. The impact of obesity and insulin resistance on the outcome of IVF or ICSI in women with polycystic ovarian syndrome. Hum Reprod 2001;16:1086\u201391. doi: 10.1093\/humrep\/16.6.1086 .","journal-title":"Hum Reprod"},{"key":"9249_CR13","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1093\/humrep\/deh485","volume":"19","author":"P Fedorcs\u00e1k","year":"2004","unstructured":"Fedorcs\u00e1k P, Dale PO, Storeng R, Ertzeid G, Bjercke S, Oldereid N, et al. Impact of overweight and underweight on assisted reproduction treatment. Hum Reprod 2004;19:2523\u20138. doi: 10.1093\/humrep\/deh485 .","journal-title":"Hum Reprod"},{"key":"9249_CR14","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1023\/A:1026477628723","volume":"17","author":"C Wittemer","year":"2000","unstructured":"Wittemer C, Ohl J, Bailly M, Bettahar-Lebugle K, Nisand I. Does body mass index of infertile women have an impact on IVF procedure and outcome? J Assist Reprod Genet 2000;17:547\u201352. doi: 10.1023\/A:1026477628723 .","journal-title":"J Assist Reprod Genet"},{"key":"9249_CR15","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.fertnstert.2006.11.162","volume":"88","author":"J Bellver","year":"2007","unstructured":"Bellver J, Melo M, Bosch E, Serra V, Remoh\u00ed J, Pellicer A. Obesity and poor reproductive outcome: the potential role of the endometrium. Fertil Steril 2007;88:446\u201351. doi: 10.1016\/j.fertnstert.2006.11.162 .","journal-title":"Fertil Steril"},{"key":"9249_CR16","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0303-7207(01)00469-5","volume":"179","author":"SG Hillier","year":"2001","unstructured":"Hillier SG. Gonadotropic control of ovarian follicular growth and development. Mol Cell Endocrinol 2001;179:36\u201346. doi: 10.1016\/S0303-7207(01)00469-5 .","journal-title":"Mol Cell Endocrinol"},{"key":"9249_CR17","first-page":"71","volume":"18","author":"BC Fauser","year":"1997","unstructured":"Fauser BC, Van Heusdon AM. Manipulation of human ovarian function: physiological concepts and clinical consequences. Endocr Rev 1997;18:71\u2013106. doi: 10.1210\/er.18.1.71 .","journal-title":"Endocr Rev"},{"key":"9249_CR18","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0015-0282(16)56211-6","volume":"60","author":"F Scheele","year":"1993","unstructured":"Scheele F, Hompes PG, Van der Meer M, Schoute E, Schoemaker J. The relationship between follicle-stimulating hormone dose and level and its relevance for ovulation induction with adjuvant gonadotropin-releasing hormone-agonist treatment. Fertil Steril 1993;60:620\u20135.","journal-title":"Fertil Steril"},{"key":"9249_CR19","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/00006254-200211000-00022","volume":"57","author":"JS Laven","year":"2002","unstructured":"Laven JS, Imani B, Eijkemans MJ, Fauser BC. New approaches to PCOS and other forms of anovulation. Obstet Gynecol Surv 2002;57:755\u201367. doi: 10.1097\/00006254-200211000-00022 .","journal-title":"Obstet Gynecol Surv"},{"key":"9249_CR20","first-page":"2248","volume":"82","author":"AE Taylor","year":"1997","unstructured":"Taylor AE, McCourt B, Martin K, Anderson EJ, Adams J, Schoebfeld D. Determinants of abnormal gonadotropin secretion in clinically defined women with PCOS. J Clin Endocrinol Metab 1997;82:2248\u201356. doi: 10.1210\/jc.82.7.2248 .","journal-title":"J Clin Endocrinol Metab"},{"key":"9249_CR21","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0015-0282(16)49931-0","volume":"47","author":"Y Yoshimura","year":"1987","unstructured":"Yoshimura Y, Wallach EE. Studies of the mechanism(s) of mammalian ovulation. Fertil Steril 1987;47:22\u201334.","journal-title":"Fertil Steril"},{"key":"9249_CR22","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/humrep\/8.suppl_2.123","volume":"8","author":"AH Balen","year":"1993","unstructured":"Balen AH, Tan SL, MacDougall J, Jacobs HS. Miscarriage rates following in-vitro fertilization are increased in women with polycystic ovaries and reduced by pituitary desensitization with buserelin. Hum Reprod 1993;8:959\u201364.","journal-title":"Hum Reprod"},{"key":"9249_CR23","first-page":"1617","volume":"84","author":"B Imani","year":"1999","unstructured":"Imani B, Eijkemans MJ, te Velde ER, Habbema JD, Fauser BC. Predictors of chances to conceive in ovulatory patients during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J Clin Endocrinol Metab 1999;84:1617\u201322. doi: 10.1210\/jc.84.5.1617 .","journal-title":"J Clin Endocrinol Metab"},{"key":"9249_CR24","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0015-0282(01)02995-8","volume":"77","author":"LG Nardo","year":"2002","unstructured":"Nardo LG, Rai R, Backos M, El Gaddal S, Regan L. High serum luteinizing hormone and testosterone concentrations do not predict pregnancy outcome in women with recurrent miscarriage. Fertil Steril 2002;77:348\u201352. doi: 10.1016\/S0015-0282(01)02995-8 .","journal-title":"Fertil Steril"},{"key":"9249_CR25","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1210\/jc.2005-2099","volume":"91","author":"YL Pag\u00e1n","year":"2006","unstructured":"Pag\u00e1n YL, Srouji SS, Jimenez Y, Emerson A, Gill S, Hall JE. Inverse relationship between luteinizing hormone and body mass index in polycystic ovarian syndrome: investigation of hypothalamic and pituitary contributions. J Clin Endocrinol Metab 2006;91:1309\u201316. doi: 10.1210\/jc.2005-2099 .","journal-title":"J Clin Endocrinol Metab"},{"key":"9249_CR26","first-page":"3728","volume":"82","author":"A Arroyo","year":"1997","unstructured":"Arroyo A, Laughlin GA, Morales AJ, Yen SS. Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity. J Clin Endocrinol Metab 1997;82:3728\u201333. doi: 10.1210\/jc.82.11.3728 .","journal-title":"J Clin Endocrinol Metab"},{"key":"9249_CR27","volume-title":"Manual for standardized investigation and diagnosis of the infertile couple","author":"World Health Organization","year":"1993","unstructured":"World Health Organization. Manual for standardized investigation and diagnosis of the infertile couple. Melbourne: Cambridge University Press; 1993."},{"key":"9249_CR28","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0015-0282(16)59660-5","volume":"49","author":"TF Kruger","year":"1988","unstructured":"Kruger TF, Acosta AA, Simmons KF, Swanson RJ, Matta JF, Oehninger S. Predictive value of abnormal sperm morphology in in vitro fertilization. Fertil Steril 1988;49:112\u20137.","journal-title":"Fertil Steril"},{"key":"9249_CR29","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/humrep\/13.1.182","volume":"13","author":"D Sakkas","year":"1998","unstructured":"Sakkas D, Shoukir Y, Chardonnens D, Bianchi PG, Campana A. Early cleavage of human embryos to the two-cell stage after intracytoplasmic sperm injection as an indicator of embryo viability. Hum Reprod 1998;13:182\u20137. doi: 10.1093\/humrep\/13.1.182 .","journal-title":"Hum Reprod"},{"key":"9249_CR30","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1093\/humrep\/15.6.1396","volume":"15","author":"J Tesarik","year":"2000","unstructured":"Tesarik J, Junca AM, Hazout A, Aubriot FX, Nathan C, Cohen-Bacrie P, et al. Embryos with high implantation potential after intracytoplasmic sperm injection can be recognized by a simple, non-invasive examination of pronuclear morphology. Hum Reprod 2000;15:1396\u20139. doi: 10.1093\/humrep\/15.6.1396 .","journal-title":"Hum Reprod"},{"key":"9249_CR31","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1093\/humrep\/15.11.2394","volume":"15","author":"L Scott","year":"2000","unstructured":"Scott L, Alvero R, Leondires M, Miller B. The morphology of human pronuclear embryos is positively related to blastocyst development and implantation. Hum Reprod 2000;15:2394\u2013403. doi: 10.1093\/humrep\/15.11.2394 .","journal-title":"Hum Reprod"},{"key":"9249_CR32","first-page":"5","volume":"4","author":"T Baczkowski","year":"2004","unstructured":"Baczkowski T, Kurzawa R, Glabowski W. Methods of embryo scoring in in vitro fertilization. Reprod Biol 2004;4:5\u201322.","journal-title":"Reprod Biol"},{"key":"9249_CR33","first-page":"S51","volume":"86","author":"Practice Committee of the Society for Assisted Reproductive Technology, Practice Committee of the American Society for Reproductive Medicine","year":"2006","unstructured":"Practice Committee of the Society for Assisted Reproductive Technology, Practice Committee of the American Society for Reproductive Medicine. Guidelines on number of embryos transferred. Fertil Steril 2006;86:S51\u20132.","journal-title":"Fertil Steril"},{"key":"9249_CR34","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/j.1471-0528.1993.tb15170.x","volume":"100","author":"AH Balen","year":"1993","unstructured":"Balen AH, Tan SL, Jacobs HS. Hypersecretion of luteinizing hormone: a significant cause of infertility and miscarriage. Br J Obstet Gynaecol 1993;100:1082\u20139.","journal-title":"Br J Obstet Gynaecol"},{"key":"9249_CR35","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S0015-0282(16)56287-6","volume":"5","author":"R Homburg","year":"1993","unstructured":"Homburg R. In vitro fertilization and embryo transfer for the treatment of infertility associated with polycystic ovary syndrome. Fertil Steril 1993;5:858\u201363.","journal-title":"Fertil Steril"},{"key":"9249_CR36","first-page":"S65","volume":"45","author":"P Ciepiela","year":"2007","unstructured":"Ciepiela P, Baczkowski T, Brelik P, Antonowicz A, Safranow K, Kurzawa R. Biotechnological and clinical outcome of in vitro fertilization in non-obese patients with polycystic ovarian syndrome. Folia Histochem Cytobiol 2007;45:S65\u201371.","journal-title":"Folia Histochem Cytobiol"},{"key":"9249_CR37","first-page":"14","volume":"13","author":"M Ashrafi","year":"2005","unstructured":"Ashrafi M, Moini A, Mohammadzadeh A, Ezabadi Z, Zafarani F, Baghestani AR. Comparative study of GnRH antagonist and GnRH agonist in PCO patients undergoing IVF\/ICSI cycles. Iranian J Reprod Med 2005;13:14\u20138.","journal-title":"Iranian J Reprod Med"},{"key":"9249_CR38","first-page":"84","volume":"50","author":"M Bahceci","year":"2005","unstructured":"Bahceci M, Ulug U, Ben-Shlomo I, Erden HF, Akman MA. Use of a GnRH antagonist in controlled ovarian hyperstimulation for assisted conception in women with polycystic ovary disease: a randomized, prospective, pilot study. J Reprod Med 2005;50:84\u201390.","journal-title":"J Reprod Med"},{"key":"9249_CR39","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1093\/humrep\/deh375","volume":"19","author":"JL Hwang","year":"2004","unstructured":"Hwang JL, Seow KM, Lin YH, Huang LW, Hsieh BC, Tsai YL, Wu Gj, Huang SC, Chen CY, Chen PH, Tzeng CR. Ovarian stimulation by concomitant administration of cetrorelix acetate and HMG following Diane-35 pre-treatment for patients with polycystic ovary syndrome: a prospective randomized study. Hum Reprod 2004;19:1993\u20132000. doi: 10.1093\/humrep\/deh375 .","journal-title":"Hum Reprod"},{"key":"9249_CR40","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/oxfordjournals.humrep.a002241","volume":"19","author":"CH Kim","year":"2004","unstructured":"Kim CH, Lee YJ, Hong SH. Efficiency of a GnRH antagonists during early and late ovarian hyperstimulation period in women with polycystic ovary syndrome undergoing IVF-ET. Hum Reprod 2004;19:105\u20139.","journal-title":"Hum Reprod"},{"key":"9249_CR41","first-page":"125","volume":"77","author":"KA Martin","year":"1993","unstructured":"Martin KA, Hall JE, Adams J, Crowley WF. Comparison of exogenous gonadotropins and pulsatile GnRH for induction of ovulation hypogonadotropic amenorrhea. J Clin Endocrinol Metab 1993;77:125\u20139. doi: 10.1210\/jc.77.1.125 .","journal-title":"J Clin Endocrinol Metab"},{"key":"9249_CR42","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0015-0282(16)57473-1","volume":"63","author":"R Homburg","year":"1995","unstructured":"Homburg R, Levy T, Ben-Rafael Z. A comparative prospective study of conventional regimen with chronic low-dose administration of follicle stimulating hormone for anovulation associated with polycystic ovary syndrome. Fertil Steril 1995;63:729\u201333.","journal-title":"Fertil Steril"},{"key":"9249_CR43","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1093\/humrep\/dem053","volume":"22","author":"A Nyboe","year":"2007","unstructured":"Nyboe A, Goossens V, Gianaroli L, Felberbaum R, de Mouzon J, Nygren KG. Assisted reproductive technology in Europe, 2003. Results generated from European registers by ESHRE. Hum Reprod 2007;22:1513\u201325. doi: 10.1093\/humrep\/dem053 .","journal-title":"Hum Reprod"},{"key":"9249_CR44","first-page":"1","volume":"56","author":"VC Wright","year":"2007","unstructured":"Wright VC, Chang J, Jeng G, Chen M, Macaluso M. Centers for Disease Control and Prevention. Assisted reproductive technology surveillance \u2014 United States, 2004. MMWR Surveill Summ 2007;56:1\u201322.","journal-title":"MMWR Surveill Summ"},{"key":"9249_CR45","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0015-0282(98)00482-8","volume":"71","author":"M Filicori","year":"1999","unstructured":"Filicori M. The role of luteinizing hormone in folliculogenesis and ovulation induction. Fertil Steril 1999;71:405\u201314. doi: 10.1016\/S0015-0282(98)00482-8 .","journal-title":"Fertil Steril"},{"key":"9249_CR46","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/oxfordjournals.humrep.a138685","volume":"9","author":"DC Schoot","year":"1994","unstructured":"Schoot DC, Harlin J, Shoham Z, Mannaerts BM, Lahlou N, Bouchard P. Recombinant human follicle-stimulating hormone and ovarian response in gonadotropin-deficient women. Hum Reprod 1994;9:1237\u201342.","journal-title":"Hum Reprod"},{"key":"9249_CR47","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/humrep\/14.2.354","volume":"14","author":"M Ludwig","year":"1999","unstructured":"Ludwig M, Finas DF, al-Hasani S. Oocyte quality and treatment outcome in intracytoplasmic sperm injection cycles of polycystic ovarian syndrome patients. Hum Reprod 1999;14:354\u20138. doi: 10.1093\/humrep\/14.2.354 .","journal-title":"Hum Reprod"},{"key":"9249_CR48","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S0015-0282(98)00007-7","volume":"69","author":"MA Okon","year":"1998","unstructured":"Okon MA, Laird SM, Tuckerman EM, Li TC. Serum androgen levels in women who have recurrent miscarriages and their correlation with markers of endometrial function. Fertil Steril 1998;69:682\u201390. doi: 10.1016\/S0015-0282(98)00007-7 .","journal-title":"Fertil Steril"},{"key":"9249_CR49","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1093\/humrep\/dei101","volume":"20","author":"S Bjercke","year":"2005","unstructured":"Bjercke S, Fedorcsak P, Abyholm T, Storeng R, Ertzeid G, Oldereid N, et al. IVF\/ICSI outcome and serum LH concentration on day 1 of ovarian stimulation with recombinant FSH under pituitary suppression. Hum Reprod 2005;20:2441\u20137. doi: 10.1093\/humrep\/dei101 .","journal-title":"Hum Reprod"},{"key":"9249_CR50","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3109\/09513590009167700","volume":"14","author":"I Noci","year":"2000","unstructured":"Noci I, Maggi M, Fuzzi B, Biagiotti R, Ricci F, Marchionni M. Effects of low day 3 luteinizing hormone levels on in vitro fertilization treatment outcome. Gynecol Endocrinol 2000;14:321\u20136.","journal-title":"Gynecol Endocrinol"},{"key":"9249_CR51","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.fertnstert.2004.06.050","volume":"83","author":"RA Cabrera","year":"2005","unstructured":"Cabrera RA, Stadtmauer L, Mayer JF, Gibbons WE, Oehninger S. Follicular phase serum levels of luteinizing hormone do not influence delivery rates in in vitro fertilization cycles down-regulated with a gonadotropin-releasing hormone agonist and stimulated with recombinant follicle-stimulating hormone. Fertil Steril 2005;83:42\u20138. doi: 10.1016\/j.fertnstert.2004.06.050 .","journal-title":"Fertil Steril"},{"key":"9249_CR52","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/humrep\/deh601","volume":"20","author":"JA Huirne","year":"2005","unstructured":"Huirne JA, van Loenen AC, Schats R, McDonnell J, Hompes PG, Schoemaker J, et al. Dose-finding study of daily GnRH antagonist for the prevention of premature LH surges in IVF\/ICSI patients: optimal changes in LH and progesterone for clinical pregnancy. Hum Reprod 2005;20:359\u201367. doi: 10.1093\/humrep\/deh601 .","journal-title":"Hum Reprod"},{"key":"9249_CR53","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.fertnstert.2004.12.015","volume":"83","author":"SY Liu","year":"2005","unstructured":"Liu SY, Han JL, Peng XD, Dong X, Xu J, Yan JM. Effect of midfollicular luteinizing hormone levels on ovarian response and pregnancy outcome in patients undergoing in vitro fertilization in a short-term protocol. Fertil Steril 2005;83:1043\u20136. doi: 10.1016\/j.fertnstert.2004.12.015 .","journal-title":"Fertil Steril"},{"key":"9249_CR54","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1093\/humrep\/deg506","volume":"18","author":"J Penarrubia","year":"2003","unstructured":"Penarrubia J, Fabregues F, Creus M, Manau D, Casamitjana R, Guimera M. LH serum levels during ovarian stimulation as predictors of ovarian response and assisted reproduction outcome in down-regulated women stimulated with recombinant FSH. Hum Reprod 2003;18:2689\u201397. doi: 10.1093\/humrep\/deg506 .","journal-title":"Hum Reprod"},{"key":"9249_CR55","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1093\/humrep\/dem033","volume":"22","author":"TG Lainas","year":"2007","unstructured":"Lainas TG, Petsas GK, Zorzovilis IZ, Iliadis GS, Kolibianakis EM. Initiation of GnRH antagonist on Day 1 of stimulation as compared to the long agonist protocol in PCOS patients. A randomized controlled trial: effect on hormonal levels and follicular development. Hum Reprod 2007;22:1540\u20136. doi: 10.1093\/humrep\/dem033 .","journal-title":"Hum Reprod"},{"key":"9249_CR56","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.fertnstert.2005.02.011","volume":"83","author":"CJM Fauser","year":"2005","unstructured":"Fauser CJM, Devroey P. Why is the clinical acceptance of gonadotropin-releasing hormone antagonist cotreatment during ovarian hyperstimulation for in vitro fertilization so slow? Fertil Steril 2005;83:1607\u201311. doi: 10.1016\/j.fertnstert.2005.02.011 .","journal-title":"Fertil Steril"}],"container-title":["Journal of Assisted Reproduction and Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-008-9249-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10815-008-9249-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-008-9249-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T01:15:48Z","timestamp":1559265348000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10815-008-9249-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":56,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["9249"],"URL":"https:\/\/doi.org\/10.1007\/s10815-008-9249-7","relation":{},"ISSN":["1058-0468","1573-7330"],"issn-type":[{"value":"1058-0468","type":"print"},{"value":"1573-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}